InsiderTrades

Form 4 for TNYA Tenaya Therapeutics, Inc.

Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-03 · accession 0001209191-21-049765 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2021-08-04 2021-08-03 TNYA Casdin Private Growth Equity Fund, L.P. 10% C - Cnv Deriv $0.00 +2.74M 362.0K New $0
DI 2021-08-04 2021-08-03 TNYA Casdin Private Growth Equity Fund, L.P. 10% P - Purchase $15.00 +850.0K 3.22M +36% +$12.75M
DMI 2021-08-04 2021-08-03 TNYA Casdin Private Growth Equity Fund, L.P. 10% C - Cnv Deriv — -2.74M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-03 C A 2,374,849 $0.00 2,374,849 I See Footnotes — — (F2) Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any. (F1) These shares are held directly by Casdin Partners Master Fund, L.P.(CPMF).
2 Common Common Stock 2021-08-03 P A 850,000 $15.00 3,224,849 I See Footnotes — — (F2) Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any. (F1) These shares are held directly by Casdin Partners Master Fund, L.P.(CPMF).
3 Common Common Stock 2021-08-03 C A 361,969 $0.00 361,969 I See Footnotes — — (F2) Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any. (F3) These shares are held directly by Casdin Private Growth Equity Fund, L.P. (CPGEF).
4 Derivative Series B Preferred Stock 2021-08-03 C D 2,012,880 — 0 I See Footnotes $0.00 · — to — 2,012,880 Common Stock (F4) Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date. (F2) Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any. (F1) These shares are held directly by Casdin Partners Master Fund, L.P.(CPMF).
5 Derivative Series C Preferred Stock 2021-08-03 C D 361,969 — 0 I See Footnotes $0.00 · — to — 361,969 Common Stock (F4) Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date. (F2) Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any. (F1) These shares are held directly by Casdin Partners Master Fund, L.P.(CPMF).
6 Derivative Series C Preferred Stock 2021-08-03 C D 361,969 — 0 I See Footnotes $0.00 · — to — 361,969 Common Stock (F4) Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date. (F2) Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any. (F3) These shares are held directly by Casdin Private Growth Equity Fund, L.P. (CPGEF).